Figure 2.

Fasting blood glucose (A), serum S100A9 (B), and serum galectin‐3 (C) levels in patients with pancreatic cancer‐associated diabetes.

Fasting blood glucose (A), serum S100A9 (B), and serum galectin‐3 (C) levels in patients with pancreatic cancer‐associated diabetes.